Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Halo Collective 1 Year Total Returns (Daily): -99.18% for June 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 25, 2024 | -99.18% |
| June 24, 2024 | -99.18% |
| June 21, 2024 | -99.17% |
| June 20, 2024 | -99.33% |
| June 18, 2024 | -99.42% |
| June 17, 2024 | -99.42% |
| June 14, 2024 | -99.47% |
| June 13, 2024 | -99.40% |
| June 12, 2024 | -99.33% |
| June 11, 2024 | -99.41% |
| June 10, 2024 | -99.41% |
| June 07, 2024 | -99.35% |
| June 06, 2024 | -99.35% |
| June 05, 2024 | -99.36% |
| June 04, 2024 | -99.36% |
| June 03, 2024 | -99.36% |
| May 31, 2024 | -99.40% |
| May 30, 2024 | -99.40% |
| May 29, 2024 | -99.40% |
| May 28, 2024 | -99.40% |
| May 24, 2024 | -99.44% |
| May 23, 2024 | -99.40% |
| May 22, 2024 | -99.40% |
| May 21, 2024 | -99.44% |
| May 20, 2024 | -99.44% |
| Date | Value |
|---|---|
| May 17, 2024 | -99.48% |
| May 16, 2024 | -99.41% |
| May 15, 2024 | -99.44% |
| May 14, 2024 | -99.43% |
| May 13, 2024 | -99.43% |
| May 10, 2024 | -99.50% |
| May 09, 2024 | -99.50% |
| May 08, 2024 | -99.50% |
| May 07, 2024 | -99.42% |
| May 06, 2024 | -99.42% |
| May 03, 2024 | -99.31% |
| May 02, 2024 | -99.38% |
| May 01, 2024 | -99.45% |
| April 30, 2024 | -99.53% |
| April 29, 2024 | -99.53% |
| April 26, 2024 | -99.47% |
| April 25, 2024 | |
| April 24, 2024 | |
| April 23, 2024 | |
| April 22, 2024 | |
| April 19, 2024 | |
| April 18, 2024 | |
| April 17, 2024 | |
| April 16, 2024 | |
| April 15, 2024 |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-100.00%
Minimum
Dec 29 2023
429.9K%
Maximum
Jul 17 2019
13.05K%
Average
-83.78%
Median
1 Year Total Returns (Daily) Benchmarks
| CEN Biotech Inc | -98.83% |
| Acasti Pharma Inc | -7.69% |
| Aurinia Pharmaceuticals Inc | -39.54% |
| Edesa Biotech Inc | -29.21% |
| Lexaria Bioscience Corp | 221.4% |